Cargando…
Crohn’s Disease Following Rituximab Treatment for Follicular Lymphoma in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review
Recently, there have been a few reports of rituximab (RTX)-induced Crohn’s disease, but there is no literature available on successful long-term treatment and the clinical outcome of this condition. We retrospectively analyzed the clinical data of a rare case of Crohn’s disease induced by RTX admini...
Autores principales: | Cavalcanti, Elisabetta, Armentano, Raffaele, Lolli, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577817/ https://www.ncbi.nlm.nih.gov/pubmed/32683839 http://dx.doi.org/10.4143/crt.2020.406 |
Ejemplares similares
-
Metastatic Gastric Signet Ring Cell Carcinoma Mimicking Crohn's Disease
por: Winter, Michael W., et al.
Publicado: (2018) -
Ileal Signet Ring Cell Carcinoma Masked by Crohn Disease
por: Hammami, Muhammad Baraa, et al.
Publicado: (2020) -
Iatrogenic Kaposi sarcoma of the terminal ileum following short-term treatment with immunomodulators for Crohn disease: A case report
por: Stasi, Elisa, et al.
Publicado: (2019) -
Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020) -
Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
por: Yim, H., et al.
Publicado: (1997)